28 May 2010

Genes' Link to Certain Cancers Questioned

Because of their small size, studies tying genes to common tumors may be invalid, researchers say


This article has not necessarily been edited by Health24.

THURSDAY, May 27 (HealthDay News) -- Small sample sizes may undercut the reliability of recent genome studies that seemingly uncovered genetic underpinnings for cancer risk, a Greek-American analysis cautions.

The observation is the result of a review of 45 studies that had harnessed technological innovations in so-called "whole genome sequencing" to attempt to identify specific genetic risk factors and link them to the risk for developing a range of cancers.

All the analyzed studies, published between 2007 and 2010, were listed in the National Human Genome Research Institute catalog.

The research team, led by Dr. John P.A. Ioannidis of the department of hygiene and epidemiology at the University of Ioannina School of Medicine in Athens, said their review of studies identified 92 genetic associations linked to the risk for developing various cancers.

More than half the highlighted genetic links concerned prostate, colorectal and/or breast cancer, they noted.

But the authors concluded that the explanatory power to predict individual cancer risk is "limited," they noted in a news release.

Ioannidis' team specifically noted that although the reviewed evidence for genetic roots to cancer risk was generally of statistical significance, the observed connections were relatively weak. They further noted that "almost all of them would also have small or very small effects."

Their findings are published in the May 26 online issue of The Journal of the National Cancer Institute.

More information

For more on genetics and cancer risk, visit the American Cancer Society.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst and Head of Advocacy Magdalene Seguin. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules